Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype
Year: 2016
Type: article
Abstract: Detecting at-risk individuals within a healthy population is critical for preventing or delaying Alzheimer's disease. Systems biology integration of brain and body metabolism enables peripheral metabolic biomarkers to serve as reporters of brain bioenergetic status. Using clinical metabolic data derived from healthy postmenopausal women in the Early versus Late Intervention Trial with Estradiol (ELITE), we conducted principal components and k-means clustering analyses of 9 biomarkers to define metabolic phenotypes. Metabolic clusters were correlated with cognitive performance and analyzed for change over 5 years. Metabolic biomarkers at baseline generated 3 clusters, representing women with healthy, high blood pressure, and poor metabolic phenotypes. Compared with healthy women, poor metabolic women had significantly lower executive, global and memory cognitive performance. Hormone therapy provided metabolic benefit to women in high blood pressure and poor metabolic phenotypes. This panel of well-established clinical peripheral biomarkers represents an initial step toward developing an affordable, rapidly deployable, and clinically relevant strategy to detect an at-risk phenotype of late-onset Alzheimer's disease.
Source: Neurobiology of Aging
Institutions: University of Southern California, Stanford University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Awards: Estrogen-Induced Neuroprotective Mitochondrial Mechanism, Metabolic and physiological biomarkers for early detection of women at risk for A, Estrogen Receptor-beta phytoSERMs for Management of Menopause and Memory Decline, Stanford Alzheimer's Disease Research Center, Los Angeles Basin Clinical and Translational Science Institute, Biologic Response of Menopausal Women to 17B-Estradiol, Perimenopause in Brain Aging and Alzheimer's Disease
OpenAlex ID: W2262606767
